- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 28.11. | GF HEALTHCARE (08143): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025 | - | HKEx | ||
| 21.11. | GF HEALTHCARE (08143): PROFIT WARNING | 1 | HKEx | ||
| GOOD FELLOW HEALTHCARE Aktie jetzt für 0€ handeln | |||||
| 11.11. | GF HEALTHCARE (08143): NOTICE OF BOARD MEETING | - | HKEx | ||
| 19.09. | GF HEALTHCARE (08143): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 19 SEPTEMBER 2025 | - | HKEx | ||
| 31.07. | GF HEALTHCARE (08143): ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2024/2025 | - | HKEx | ||
| 31.07. | GF HEALTHCARE (08143): FORM OF PROXY FOR ANNUAL GENERAL MEETING | - | HKEx | ||
| 31.07. | GF HEALTHCARE (08143): NOTICE OF ANNUAL GENERAL MEETING | - | HKEx | ||
| 31.07. | GF HEALTHCARE (08143): (1) PROPOSED GRANT OF GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES; (2) PROPOSED RE-ELECTION OF RETIRING DIRECTORS AND CONTINUOUS ... | - | HKEx | ||
| 31.07. | GF HEALTHCARE (08143): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS | - | HKEx | ||
| 31.07. | GF HEALTHCARE (08143): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS | - | HKEx | ||
| 31.07. | GF HEALTHCARE (08143): ANNUAL REPORT 2024/2025 | - | HKEx | ||
| 30.06. | GF HEALTHCARE (08143): TERMS OF REFERENCE OF THE NOMINATION AND CORPORATE GOVERNANCE COMMITTEE | - | HKEx | ||
| 30.06. | GF HEALTHCARE (08143): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 30.06. | GF HEALTHCARE (08143): COMPANY INFORMATION SHEET | - | HKEx | ||
| 27.06. | GF HEALTHCARE (08143): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 MARCH 2025 | - | HKEx | ||
| 26.06. | GF HEALTHCARE (08143): ANNOUNCEMENT RESULTS OF THE RIGHTS ISSUE ON THE BASIS OF ONE (1) RIGHTS SHARE FOR EVERY ONE (1) EXISTING SHARE HELD ON THE RECORD ... | - | HKEx | ||
| 19.06. | GF HEALTHCARE (08143): SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR | - | HKEx | ||
| 12.06. | GF HEALTHCARE (08143): ANNOUNCEMENT RESULTS OF VALID ACCEPTANCES OF THE RIGHTS SHARES AND NUMBER OF UNSUBSCRIBED RIGHTS SHARES AND ES UNSOLD RIGHTS SHARES ... | - | HKEx |
18 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 43,510 | +1,92 % | EQS-PVR: Siemens Healthineers AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Siemens Healthineers AG
Siemens Healthineers AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
01.12.2025 /... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,040 | +0,08 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 35,790 | +1,79 % | IPO Stock Of The Week: Health Care Leader BrightSpring Falls Back Into Buying Range | ||
| PROCEPT BIOROBOTICS | 35,860 | +1,21 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| FRESENIUS | 47,720 | -0,60 % | DZ BANK stuft Fresenius SE auf 'Kaufen' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Aktienwert für Fresenius nach den Anfang November vorgelegten Zahlen zum dritten Quartal von 56 auf 57 Euro angehoben. Die Einstufung wurde... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,550 | +0,77 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| PROGYNY | 24,020 | -0,54 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| GENEDX | 158,96 | -1,85 % | Cathie Wood's ARK sells Iridium, buys GeneDx and WeRide stock | ||
| BETA BIONICS | 29,380 | -2,07 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| NUTEX HEALTH | 160,95 | +2,65 % | Nutex Health extends share repurchase plan | ||
| GERRESHEIMER | 25,860 | -1,52 % | INDEX-MONITOR: JPMorgan erwartet Aumovio im MDax - Dax wohl unverändert | FRANKFURT (dpa-AFX) - Im Dax dürfte zur Index-Überprüfung an diesem Mittwoch alles beim Alten bleiben. Eine Änderung erwartet die US-Bank JPMorgan dagegen im Index der mittelgroßen Unternehmen, die... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 9,310 | +1,92 % | Aveanna Healthcare stock price target raised to $13 by Raymond James | ||
| CARL ZEISS MEDITEC | 43,440 | +0,32 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen | |
| CERIBELL | 19,720 | +2,98 % | Ceribell Reports Third Quarter 2025 Financial Results | SUNNYVALE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with... ► Artikel lesen | |
| GOODRX | 2,710 | -1,45 % | HIMS vs. GDRX: Which Consumer Health Stock Offers Greater Upside? |
GOOD FELLOW HEALTHCARE HOLDINGS LTD gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GOOD FELLOW HEALTHCARE HOLDINGS LTD finden Sie auf Wallstreet Online.